April 20, 2016
Biogen Japan said on April 19 that it has filed a new drug application in Japan for its multiple sclerosis (MS) treatment dimethyl fumarate. The capsule drug, known as Tecfidera overseas, is expected to be indicated for preventing MS relapses...read more